DOCUMENTATION & CONTEXT
Growth & Secretagogue Peptides
CJC-1295 with Ipamorelin
10 mg Vial
This preparation combines CJC-1295 without DAC, a modified 29-amino-acid growth-hormone-releasing hormone analogue, with Ipamorelin, a selective pentapeptide agonist of the growth hormone secretagogue receptor. The two are supplied together as a single 10 mg lyophilised vial for in-vitro work in which both points of the same signalling axis are examined under one experimental condition.
In stock
£30.00
Supplied strictly for in-vitro laboratory research. Not for human or veterinary use, or for the diagnosis, treatment or prevention of disease. This page provides no directions for human or veterinary use.
FORMAT OPTIONS
Choose the relevant format.
Format options are shown as separate research-material entries. Review the relevant entry and its documentation before procurement.
CORE RESEARCH DOCUMENTATION-LED PROCUREMENT
Continue your laboratory review.
Return to the catalogue or consult batch documentation while keeping the research-use boundary in view.